New blood vials pass sepsis detection test
NCT ID NCT06426121
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested whether a new type of blood culture vial works as well as the standard one for detecting sepsis. Researchers collected extra blood samples from 394 patients with suspected bloodstream infections and compared results between the two vials. The goal was to see if the new vials give consistent positive and negative results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- BACTEC Plus Aerobic/F culture vials
- What this could lead to
- If successful, this could confirm that the new vials are a reliable alternative for detecting bloodstream infections, potentially improving lab efficiency.
- What could go wrong
- This is a completed validation study, not a treatment trial. It only checks if the new vials match standard ones—it does not test any new therapy or cure for sepsis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SEPSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Peking University People's Hospital
Beijing, Beijing Municipality, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can we optimize antibiotic dosing for children with sepsis?
- Could starting feeds sooner shield preterm babies from infection?
- Can brain waves predict thinking problems after sepsis?
- Can tailored nutrition boost recovery in the ICU?
- Blood markers may foretell brain fog after sepsis
- A hidden clue in the fingertips: could a pulse oximeter reading forecast sepsis outcomes?